see ttab records
on 20 Aug 2019
Last Applicant/ Owned by
748 Blvd Veterans
Sherbrooke
CA
Serial Number
87431283 filed on 30th Apr 2017
Registration Number
5558464 registered on 11th Sep 2018
Correspondent Address
JEFFREY A LINDENBAUM
COLLEN IP INTELLECTUAL PROPERTY LAW PC
THE HOLYOKE MANHATTAN BUILDING 80 SOUTH
HIGHLAND AVENUE
OSSINING, NY 10562
Filing Basis
No Filing Basis
Disclaimer
NO DATA
Beverages containing fish oils, minerals, vitamins, for use as a nutritional supplement; Chemical preparations for pharmaceutical or medical purposes, namely, for attention-deficit/hyperactivity disorder (ADHD), autism, depression, cognitive impairment, Alzheimer's disease, Parkinson's disease, anxiety, mood disorder, nervous degenerative trouble, migraine; Delivery agents in the form of powder, lRead More
Beverages containing fish oils, minerals, vitamins, for use as a nutritional supplement; Chemical preparations for pharmaceutical or medical purposes, namely, for attention-deficit/hyperactivity disorder (ADHD), autism, depression, cognitive impairment, Alzheimer's disease, Parkinson's disease, anxiety, mood disorder, nervous degenerative trouble, migraine; Delivery agents in the form of powder, liquid, capsules, tablets, gel that facilitate the delivery of nutritional supplements; Dietary and nutritional supplements; Dietary and nutritional supplements containing fish oils, minerals, vitamins, plant oil; Dietary beverage supplements for human consumption in liquid and dry mix form for therapeutic purposes; Dietary food supplements; Dietary supplement beverage for attention-deficit/hyperactivity disorder (ADHD), autism, depression, cognitive impairment, Alzheimer's disease, Parkinson's disease, anxiety, mood disorder, nervous degenerative trouble, migraine; Dietary supplement drink mixes; Dietary supplemental drinks; Dietary supplemental drinks in the nature of vitamin and mineral beverages; Dietary supplements; Dietary supplements also containing minerals, vitamins, oils; Dietary supplements for human consumption; Dietary supplements for attention-deficit/hyperactivity disorder (ADHD), autism, depression, cognitive impairment, Alzheimer's disease, Parkinson's disease, anxiety, mood disorder, nervous degenerative trouble, migraine; Dietetic beverages adapted for medical use; Dietetic foods adapted for medical purposes; Dietetic foods and beverages adapted for medical use; Dietetic foods for treating attention-deficit/hyperactivity disorder (ADHD), autism, depression, cognitive impairment, Alzheimer's disease, Parkinson's disease, anxiety, mood disorder, nervous degenerative trouble, migraine; Edible fish oils, mineral preparations, vitamins, and medicinal plant oils adapted for medical use; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of powder, liquid, capsules, tablets, gel that facilitate the delivery of pharmaceutical preparations; Edible fish oils for medical purposes; Food supplements; Food supplements for attention-deficit/hyperactivity disorder (ADHD), autism, depression, cognitive impairment, Alzheimer's disease, Parkinson's disease, anxiety, mood disorder, nervous degenerative trouble, migraine; Gummy vitamins; Liquid nutritional supplement; Liquid vitamin supplements; Medicaments for attention-deficit/hyperactivity disorder (ADHD), autism, depression, cognitive impairment, Alzheimer's disease, Parkinson 's disease, anxiety, mood disorder, nervous degenerative trouble, migraine; Medicated water for the treatment of attention-deficit/hyperactivity disorder (ADHD), autism, depression, cognitive impairment, Alzheimer's disease, Parkinson's disease, anxiety, mood disorder, nervous degenerative trouble, migraine; Medicinal drinks; Migraine treatment preparations; Mineral food supplements; Mineral nutritional supplements; Mineral supplements; Mineral, vitamin, or nutritionally enhanced water for medical purposes; Mixed vitamin preparations; Multi-vitamin preparations; Multivitamin preparations; Natural dietary supplements; Natural dietary supplements for the treatment of attentiondeficit/hyperactivity disorder (ADHD), autism, depression, cognitive impairment, Alzheimer's disease, Parkinson's disease, anxiety, mood disorder, nervous degenerative trouble, migraine; Natural supplements for treating depression and anxiety; Nutraceuticals for the treatment of attention-deficit/hyperactivity disorder (ADHD), autism, depression, cognitive impairment, Alzheimer's disease, Parkinson's disease, anxiety, mood disorder, nervous degenerative trouble, migraine; Nutraceuticals for use as a dietary supplement; Nutraceuticals for use as a dietary supplement for attention-deficit/hyperactivity disorder (ADHD), autism, depression, cognitive impairment, Alzheimer's disease, Parkinson's disease, anxiety, mood disorder, nervous degenerative trouble, migraine; Nutritional and dietary supplements formed and packaged as bars; Nutritional supplement energy bars; Nutritional supplement shakes; Nutritional supplements; Nutritional supplements consisting primarily of Omega3 oil, vitamins, vitamin B6, minerals, zinc, magnesium; Nutritional supplements for attention-deficit/hyperactivity disorder (ADHD), autism, depression, cognitive impairment, Alzheimer's disease, Parkinson's disease, anxiety, mood disorder, nervous degenerative trouble, migraine; Nutritional supplements in the form of powder, liquid, capsules, tablets, gel; Nutritional supplements, namely, probiotic compositions; Nutritionally fortified beverages for medical purposes; Nutritionally fortified water for medical purposes; Pharmaceutical preparations and substances for the treatment of psychiatric diseases and disorders; Pharmaceutical preparations for peripheral nervous system; Pharmaceutical preparations for the treatment and prevention of attention-deficit/hyperactivity disorder (ADHD), autism, depression, cognitive impairment, Alzheimer's disease, Parkinson's disease, anxiety, mood disorder, nervous degenerative trouble, migraine; Pharmaceutical preparations for the treatment of attention-deficit/hyperactivity disorder (ADHD), autism, depression, cognitive impairment, Alzheimer's disease, Parkinson's disease, anxiety, mood disorder, nervous degenerative trouble, migraine; Pharmaceutical preparations for treating chemical imbalances; Powdered nutritional supplement concentrate; Powdered nutritional supplement drink mix; Powdered nutritional supplement drink mix and concentrate; Powdered nutritional supplement drink mix containing fish oils, vitamins, minerals, plant oils; Therapeutic pharmaceutical for the treatment of attention-deficit/hyperactivity disorder (ADHD), autism, depression, cognitive impairment, Alzheimer's disease, Parkinson's disease, anxiety, mood disorder, nervous degenerative trouble, migraine; Vitamin and mineral formed and packaged as bars; Vitamin and mineral preparations for medical use; Vitamin and mineral supplements; Vitamin and mineral supplements for mixing with food and beverages; Vitamin B preparations; Vitamin fortified beverages for medical purposes; Vitamin preparations; Vitamin supplements; Vitamin tablets; Vitamins; Vitamins and vitamin preparations
No 87431283
No Service/Collective Mark
No
No
No
Yes
Yes
No
No
No
No
Status Date | Action Taken |
---|---|
11th Sep 2023 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
20th Aug 2019 | CANCELLATION DENIED NO. 999999 |
20th Aug 2019 | CANCELLATION TERMINATED NO. 999999 |
20th Aug 2019 | TTAB RELEASE CASE TO TRADEMARKS |
01st Oct 2018 | CANCELLATION INSTITUTED NO. 999999 |
11th Sep 2018 | REGISTERED-PRINCIPAL REGISTER |
26th Jun 2018 | PUBLISHED FOR OPPOSITION |
26th Jun 2018 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
06th Jun 2018 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
23rd May 2018 | ELECTRONIC RECORD REVIEW COMPLETE |